AUS
NZ
UK
CA
USA
IND
Healthcare
Lifespot Health provides operations update; Cannabis category expected to hit $166 billion by 2025!
April 08, 2019 04:43 PM AEST| By Team Kalkine MediaLifespot Health Ltd (ASX: LSH) functions in the digital health sector and is primarily focused on building and commercializing medical monitoring and diagnostic expertise. The company, today, on 8th April 2019, released to the ASX its operational upd...
Is This Beaten Down Pot Stock Gaining The Lost Fizz- Creso Pharma CPH
April 06, 2019 08:45 AM AEDT| By Team Kalkine MediaCreso Pharma Limited (ASX: CPH) develops and markets pharmaceutical-grade cannabis and hemp-based nutraceutical products along with the health treatments for human and animal in Australia, Canada, Israel, Colombia, and Switzerland. Its five key areas...
THC Global Continues Global Expansion Through Commercial Partnerships
April 05, 2019 09:04 PM AEDT| By Team Kalkine MediaTHC Global Group Limited (ASX: THC) operates as a pharmaceutical company. The company develops cannabis, as well as focuses on the manufacturing and distribution of hydroponics equipment, materials and nutrients. THC Global Group serves customers in...
A Closer Look At Creso Pharma’s Response To The ASX’s Aware Query
April 05, 2019 06:56 PM AEDT| By Team Kalkine MediaCreso Pharma Limited (ASX: CPH) is in the cannabis industry working to deliver quality products to humans as well as for animals. The company is first to import cannabis for medical use into Australia. It is also first to launch innovative products i...
Antisense Therapeutics Updates Ubout The Phase II Clinical Trial Of Its Immunomodulatory Therapy
April 04, 2019 10:15 PM AEDT| By Team Kalkine MediaAntisense Therapeutics Limited (ASX: ANP) is an ASX listed biopharmaceutical company, which is aiming to develop and commercialise antisense pharmaceuticals, for the huge untouched markets. Also, Ionis Pharmaceuticals Inc. which is based in the US an...
Estia Health expects to bag additional revenue beyond its earnings guidance
April 04, 2019 04:24 PM AEDT| By Team Kalkine MediaEstia Health Limited today announced an increase in its existing earning guidance for the Fiscal Year 2019 on the back of additional revenue estimated to be earned during the remaining period. In the announcement dated 4 April 2019, Estia Health Lim...
Acrux announces settlement of its Hatch-Waxman patent litigation for Jublia®
April 03, 2019 10:59 PM AEDT| By Team Kalkine MediaAcrux Limited (ASX: ACR) is in the business of pharmaceutical having a keen interest in developing and commercialising topical pharmaceuticals. It is developing a range of topical and dermatological generic products for the US markets by leveraging i...
Imugene released research study of PD-1 mimotope cancer vaccine
April 03, 2019 05:35 PM AEDT| By Team Kalkine MediaImugene Limited (ASX: IMU) is a biotechnology company, having operations in America and Europe is working specifically in the clinical stage of immuno-oncology. Immuno-oncology is an area of research that helps the body to fight cancer through its ow...
Wattle Health Reveals Key Insights At Credit Suisse' Dairy Day
April 03, 2019 05:34 PM AEDT| By Team Kalkine MediaWattle Health Australia Limited (ASX: WHA) aims to promote health and wellness at all stages by providing organic and sustainable products. It uses natural ingredients for its products that are derived from Australiaâs pure water, clean air.....
Mediland Pharm Enters Into Agreement To Acquire Ian’s Health Lounge
April 03, 2019 02:08 PM AEDT| By Team Kalkine MediaMediland Pharm Limited (ASX: MPH) is an ASX listed company working in the health sector and is based in Sydney, Australia. The company has retail operations in Sydney, Melbourne and the Gold Coast through which it is aiming to deliver the best of the...
MGC Pharmaceuticals announces 2019 commercialisation strategy
April 03, 2019 01:51 PM AEDT| By Team Kalkine MediaMGC Pharmaceuticals Ltd (ASX: MXC) is an EU bio-pharma company which develops and commercialises a cost-effective portfolio of medicinal cannabis products across Europe, North America and Australasia. On April 2nd, 2019, MGC released an update on its...
Sienna Buys Liquid Biopsy & Exosome Isolation Technology
April 02, 2019 11:03 PM AEDT| By Team Kalkine MediaSienna Cancer Diagnostics Limited (ASX: SDX) is a provider of health care services. The company offers pharmaceutical and biotechnology research and development, commercialisation, manufacturing operation, and other related services for clinical diag...
Creso Pharma’s Commercial Progress Across All Product Categories; Stock Price Shoots Up 10.26%
April 02, 2019 10:56 PM AEDT| By Team Kalkine MediaCreso Pharma Limited (ASX: CPH), established in 2015 and based out of New South Wales, Australia, develops and commercialises pharmaceutical-grade cannabis and hemp derived therapeutic, nutraceutical, and lifestyle products for patients and consumers...
CardieX And inHealth Collaborate For A Ground-Breaking Commercial Study On Cardiovascular Disease
April 02, 2019 06:15 PM AEDT| By Team Kalkine MediaCardieX Limited (ASX: CDX) is working in the space of health technology at the global level. It aims to provide health solutions for large scale population through digital and device-based solutions. The company has developed a product named XCEL whi...
Imugene Presented New Data On the KEY-Vaxx & B-Vaxx Cancer Vaccine
April 02, 2019 03:09 PM AEDT| By Team Kalkine MediaImugene Limited (ASX: IMU) is an immuno-oncology company, which is into the clinical stage. The company is engaged in the operations of developing a range of new and novel immunotherapies that has an objective of activating the immune system of cance...
AirXpanders Announces Voluntary Suspension As Operational Review And Capital Raising Discussions Are Underway
April 02, 2019 02:42 PM AEDT| By Team Kalkine MediaMedical device company AirXpanders, Inc. (ASX: AXP) today announced the voluntary suspension of trading of its securities as it undertakes the review of various matters pertaining to its operations, including resolving an anticipated debt covenant br...
Producer Of Hemp-Based Products, Ecofibre Limited Makes A Debut On ASX
April 01, 2019 08:16 PM AEDT| By Team Kalkine MediaListed under the health care industry, Ecofibre Limited (ASX: EOF) commenced trading on the Australian Securities Exchange on 29 March 2019. On 1 April 2019, Ecofibre informed that its directors Eric Wang, Barry Lambert, and Jon Meadmore hold approx...
CardieX Limited Provides Interim Corporate Update
April 01, 2019 06:00 PM AEDT| By Team Kalkine MediaOn 1 April 2019, CardieX Limited (ASX: CDX), a company from the healthcare sector engaged into the development and marketing of the SphygmoCor device has reported various corporate activities for its business and its operating subsidiaries for the ca...
Kazia Therapeutics Announces Cantrixil Phase 1 Study Part A Results
April 01, 2019 05:42 PM AEDT| By Team Kalkine MediaThe Sydney, Australia-based Kazia Therapeutics Limited (ASX: KZA) is an innovative biotechnology company focussed on oncology. Their pipeline includes two clinical-stage drug development candidates including GDC-0084, a small molecule inhibitor of th...
Exopharm Updates The Market On The Progress Of The Development Program
April 01, 2019 05:15 PM AEDT| By Team Kalkine MediaOn 1 April 2019, a biopharmaceutical company, Exopharm Limited (ASX: EX1) released a market update on the advancement of the Development program and about its evolution into a clinical stage drug development company. The key attention of the company...
Advertise your brand on Kalkine Media